Most pharmacy sellers focus on what their business is worth. The more productive preparation question is what a buyer can verify and what HMRC will charge on the gain. Getting both right is the work of the two to three years before you exchange, not the two to three weeks.
This guide sets out the two levers: a clean, defensible margin story that supports the price a buyer will pay, and Business Asset Disposal Relief (BADR) eligibility and timing that determines the tax you keep. Both require planning well in advance.
The two levers: price and tax
A pharmacy buyer's offer reflects two things: the income they can verify in your accounts, and the risk they price in for what they cannot. A seller's tax bill on the resulting gain reflects the BADR rate that applied on the day of disposal and whether the qualifying conditions were met at that point.
The two levers are independent. You can have immaculate accounts and poor BADR preparation, or the reverse. Both are controllable, both require time, and both directly determine how much you put in your pocket.
For an overview of the sale process and what to expect as a seller, see the selling a pharmacy hub.
Clean, reconciled accounts a buyer's due diligence will trust
A pharmacy's accounts look unusual to anyone trained on ordinary trade businesses. Income is not till-driven: it is reimbursement (Drug Tariff prices) plus remuneration (fees and service payments) under the Community Pharmacy Contractual Framework, flowing through a monthly FP34 NHSBSA payment cycle with a roughly two-month lag between submission and receipt. A buyer's accountant knows this. What they are checking is whether your records reflect it accurately and consistently.
The specific lines they will interrogate are:
- FP34 payment history. Three years of NHSBSA payment schedules reconciled to your bank statements. Missing months, unexplained credits, or advance-on-account balances that do not tie to the payment log are the first red flag.
- Drug Tariff margin variances. Under the Drug Tariff and Category M clawback mechanism, gross margin is set centrally and retrospectively adjusted. If your accounts show margin swings with no corresponding note or management explanation, a buyer will discount the revenue quality. The fix is a margin-variance note in your management accounts, not a restatement.
- VAT treatment. A community pharmacy is a VAT-mixed business: NHS-dispensed prescription drugs are zero-rated, most OTC retail is standard-rated. Your retail scheme (the mechanic for splitting takings) must be disclosed and consistent across the three years. A buyer's accountant will check that the scheme chosen is appropriate and that the zero-rated/standard-rated split is defensible. Inconsistent treatment is an audit risk that transfers to the buyer on a share purchase.
- Retail and service income separated. OTC retail sales and growing service lines such as Pharmacy First should be separately coded, not lumped into a single income line. Buyers pay for visibility, not aggregation.
Three years of clean, consistently coded management accounts with a margin-variance note and an FP34 reconciliation schedule is the minimum a credible buyer process requires. Start the cleanup now if those records are not already in that shape.
The margin story: evidencing Drug Tariff and Category M margin
Pharmacy valuation depends heavily on the quality and defensibility of the income, not just its size. Because Drug Tariff and Category M pricing is set centrally and retrospectively adjusted, gross margin in a pharmacy varies in ways that are outside the owner's control. A buyer who does not understand this will either price the risk in (lower offer) or walk away.
The margin story is the narrative that explains variance: which months were affected by Drug Tariff adjustments, how the business responded, what the underlying dispensing volume trend is, and how the retail and service income lines diversify the revenue base. It is not a restatement of the accounts; it is the management commentary that makes the accounts intelligible to a buyer who is spending serious money.
A well-prepared margin story includes:
- A three-year margin-by-revenue-line table (NHS reimbursement, NHS remuneration, OTC retail, services) showing the split and the trend.
- Annotations for significant Drug Tariff adjustment months so a buyer can separate structural performance from external price movements.
- Dispensing volume data (items per month) as a proxy for the NHS contract strength, which is the core asset being acquired.
- A brief note on Pharmacy First and other service income growth, showing the trajectory as a separate line.
Buyers pay a premium for earnings quality they can verify and a discount for earnings they cannot explain. The margin story is the document that shifts the negotiation in your direction.
For a detailed look at how goodwill and valuation methods work in pharmacy transactions, see the pharmacy goodwill valuation post.
Business Asset Disposal Relief: what qualifies and how to prepare
Business Asset Disposal Relief (BADR) reduces the capital gains tax rate on qualifying disposals to 18% for 2026/27, on gains up to a £1m lifetime limit per person. It is one of the most significant tax reliefs available to a pharmacy owner who is exiting, but it requires that the qualifying conditions are met at the date of disposal, not just around it.
The core qualifying conditions for a disposal of shares in a personal company are:
- You must have held the shares for at least two years before the date of disposal.
- Throughout that two-year period, the company must have been a trading company (or the holding company of a trading group).
- You must have held at least 5% of the ordinary share capital and at least 5% of the voting rights throughout the two years.
- You must have been an officer or employee of the company throughout the two years.
For a sole-trader or partnership disposal, the business must have been owned and operated as a qualifying trade for at least two years before disposal.
Two preparation points matter most in practice. First, any restructuring (incorporating a sole-trader business, changing the share structure, admitting a new director, or converting to a holding company) resets or complicates the two-year clock. Run any planned restructuring past a specialist before signing anything, not after. Second, the £1m lifetime limit is per person. If you have used part of the allowance on a previous qualifying disposal, only the remainder is available. Check your position now so there are no surprises at the point of a sale.
For a full tax computation, visit the pharmacy sale CGT and BADR service page or speak to us directly about your specific situation.
Timing around the BADR rate steps
The BADR rate has changed twice in recent years and may change again. The history matters because a disposal date determines which rate applies:
| Tax year | BADR rate on qualifying gains (up to £1m lifetime limit) |
|---|---|
| Before 2025/26 | 10% |
| 2025/26 (6 April 2025 to 5 April 2026) | 14% |
| 2026/27 (6 April 2026 onwards) | 18% |
Source: gov.uk/business-asset-disposal-relief.
To make the rate-step arithmetic concrete, the table below illustrates the difference on a qualifying gain of £500,000 (fully within the £1m BADR lifetime limit, figures illustrative and for planning purposes only):
| Disposal year | BADR rate | CGT on £500,000 qualifying gain (illustrative) |
|---|---|---|
| 2025/26 | 14% | £70,000 |
| 2026/27 | 18% | £90,000 |
| Difference | 4 percentage points | £20,000 more tax in 2026/27 on the same gain |
These figures are illustrative. They do not account for the annual exempt amount, any gains within the basic-rate band, deferred consideration or earn-out timing, or any individual circumstances that would change the calculation. The point is structural: four percentage points on a £500,000 gain is £20,000. On a gain closer to the £1m limit the number doubles. Disposal timing is a real financial decision, not a formality.
The rate as announced for 2026/27 is 18%. HMRC can change the rate in a future Budget; there is no published commitment to hold it there. If your BADR remaining lifetime allowance is substantial and your exit is within reach, the timing calculation is worth running properly before you commit to a target completion date.
To discuss the numbers for your situation, speak to us or visit the pharmacy sale CGT and BADR service page.
Beyond BADR: standard CGT if the gain exceeds the limit
Where your gain exceeds the £1m BADR lifetime limit, or where BADR does not apply for any reason, the excess gain is subject to standard CGT rates:
- 18% on gains that fall within the remaining basic-rate band (after income for the year has been taken into account).
- 24% on gains above the basic-rate band.
The annual exempt amount is frozen at £3,000 for 2026/27. It is deducted from the total gain before the rate is applied, but at the values common in pharmacy transactions it makes a small difference to the total bill.
A pharmacy is treated as a non-residential asset for the rate-band split. That means the 18%/24% split applies (not the residential property rates), regardless of whether the pharmacy premises are owned or leased.
Two structuring points are worth understanding early. First, earn-outs and deferred consideration change when the tax falls due: a gain on a deferred payment is generally taxed in the year the payment is received (or the right to it becomes unconditional), not the year of exchange. This can spread the tax across two or more years and interact with the basic-rate band each year. Second, if the sale is structured as a share purchase, the CGT is on the gain on the shares, not on the underlying business assets separately. If structured as an asset purchase, each class of asset may have its own CGT treatment. The choice of deal structure changes both the tax liability and the BADR eligibility calculation.
These are areas where a specialist computation matters. For modelling your specific numbers, contact us or see the pharmacy sale CGT and BADR service.
Building the timeline: what to fix now versus at deal time
Most of the work that moves a pharmacy sale outcome sits in the period before a buyer is at the table, not after. The table below splits the main preparation tasks by when to tackle them.
| Area | What a buyer or adviser checks | Fix now (2+ years out) | Deal-time (3 to 6 months from exchange) |
|---|---|---|---|
| FP34 payment history | NHSBSA payment schedule reconciled to bank | Request and file monthly; reconcile any gaps | Assemble three-year schedule for data room |
| Drug Tariff margin variances | Explained variance by month | Add management-account annotations now | Prepare margin-story narrative document |
| VAT retail scheme | Scheme is appropriate and consistently applied | Review choice and document the basis | Confirm three-year consistency in disclosure |
| Revenue separation | NHS reimbursement / remuneration / OTC / services coded separately | Recode the chart of accounts if mixed | Produce revenue-by-line three-year summary |
| BADR qualifying period | Two-year ownership, officer/employment, 5% shares and votes | Verify position now; flag restructuring risks | Confirm qualifying conditions are still met at exchange date |
| BADR lifetime limit | Prior qualifying disposals and limit remaining | Check prior use of the allowance | Confirm remaining limit before heads of terms |
| Deal structure | Share vs asset purchase; earn-out mechanics | Understand the default structure for your situation | Agree structure before heads of terms are signed |
| GPhC and NHS regulatory steps | Registration, superintendent pharmacist, 2013 Regulations consent | Understand the regulatory timeline (it is long) | Trigger regulatory process in parallel with legal |
The regulatory timeline under the NHS (Pharmaceutical and Local Pharmaceutical Services) Regulations 2013 and the GPhC registration requirements for a change of ownership is not fast. It runs in parallel with the legal process, not after it. Build it into your overall plan from the start.
Next steps
Preparing a pharmacy for sale is a two to three year project if the accounts need work or the BADR qualifying conditions are not yet in place. The earlier you start, the more of the preparation is controlled rather than rushed.
The selling a pharmacy hub sets out how specialist accountants support the sale process from preparation through to completion and post-deal tax filing. For a conversation about your specific situation, including a BADR eligibility check and a sense of the tax landscape on your expected gain, get in touch.